Roche laid out its ambitions in the social part of its environmental, social and governance (ESG) strategy on Monday centered on access to its drugs and diagnostics.
The Roche inaugural Access to Healthcare investor call follows a general pharma industry trend in ESG. More companies are publishing reports and holding…
